VeriChip Corporation, which develops and sells radio frequency identification systems, primarily for use in the healthcare industry, revised the terms for its proposed IPO on Friday morning. The company now plans to sell 3.1 million shares, down from 4.3 million, at $6.50, the low end of its proposed $6.50 to $8.50 range. Lead underwriter Merriman Curhan plans to price the IPO later on Friday.
